{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:16:41Z","timestamp":1792163801653,"version":"4.4.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med Bull"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1093\/bmb\/ldv017","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T07:28:26Z","timestamp":1439969306000},"page":"169-179","source":"Crossref","is-referenced-by-count":455,"title":["Antipsychotic medication in schizophrenia: a review"],"prefix":"10.1093","volume":"114","author":[{"given":"John","family":"Lally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"MacCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,5,8]]},"reference":[{"key":"2015081904281628000_114.1.169.1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-25761-2_2"},{"key":"2015081904281628000_114.1.169.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01251-3"},{"key":"2015081904281628000_114.1.169.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62036-X"},{"key":"2015081904281628000_114.1.169.4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.4.514"},{"key":"2015081904281628000_114.1.169.5","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/18.3.515"},{"key":"2015081904281628000_114.1.169.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"2015081904281628000_114.1.169.7","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.10.1079"},{"key":"2015081904281628000_114.1.169.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60239-6"},{"key":"2015081904281628000_114.1.169.9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.096594"},{"key":"2015081904281628000_114.1.169.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"2015081904281628000_114.1.169.11","doi-asserted-by":"crossref","unstructured":"Newcomer JW . Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005;1:1\u201393.","DOI":"10.2165\/00023210-200519001-00001"},{"key":"2015081904281628000_114.1.169.12","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbr148"},{"key":"2015081904281628000_114.1.169.13","doi-asserted-by":"crossref","unstructured":"Allison DB Mentore JL Heo M Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686\u201396.","DOI":"10.1176\/ajp.156.11.1686"},{"key":"2015081904281628000_114.1.169.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094112"},{"key":"2015081904281628000_114.1.169.15","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.142521"},{"key":"2015081904281628000_114.1.169.16","unstructured":"NICE. Psychosis and schizophrenia in adults: treatment and management (Clinical guideline 178). London: Royal College of Psychiatrists, 2014."},{"key":"2015081904281628000_114.1.169.17","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.12.1228"},{"key":"2015081904281628000_114.1.169.18","unstructured":"Taylor D Paton C Kapur S . The Maudsley Prescribing Guidelines in Psychiatry. Wiley, 2012."},{"key":"2015081904281628000_114.1.169.19","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.3.241"},{"key":"2015081904281628000_114.1.169.20","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.110.081471"},{"key":"2015081904281628000_114.1.169.21","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.105833"},{"key":"2015081904281628000_114.1.169.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60742-X"},{"key":"2015081904281628000_114.1.169.23","doi-asserted-by":"publisher","DOI":"10.1176\/ps.49.2.196"},{"key":"2015081904281628000_114.1.169.24","unstructured":"Leucht S Heres S . Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry 2006;5:3\u20138."},{"key":"2015081904281628000_114.1.169.25","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.08r00612"},{"key":"2015081904281628000_114.1.169.26","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp121"},{"key":"2015081904281628000_114.1.169.27","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10081224"},{"key":"2015081904281628000_114.1.169.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005987"},{"key":"2015081904281628000_114.1.169.29","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn018"},{"key":"2015081904281628000_114.1.169.30","unstructured":"Royal College of Psychiatrists. Consensus statement on high-dose antipsychotic medication (CR190). London: Royal College of Psychiatrists, 2014."},{"key":"2015081904281628000_114.1.169.31","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12025"},{"key":"2015081904281628000_114.1.169.32","unstructured":"NICE. National Institute for Health and Clinical Excellence. Bipolar disorder (update): the management of bipolar disorder in adults, children and adolescents in primary and secondary care. (Clinical Guideline 185). London: NICE, 2014."},{"key":"2015081904281628000_114.1.169.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60873-8"},{"key":"2015081904281628000_114.1.169.34","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2013.804195"},{"key":"2015081904281628000_114.1.169.35","unstructured":"Joint Formulary Committee. British National Formulary (BNF) 67. Pharmaceutical Press, 2014."},{"key":"2015081904281628000_114.1.169.36","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbt046"},{"key":"2015081904281628000_114.1.169.37","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674"},{"key":"2015081904281628000_114.1.169.38","doi-asserted-by":"crossref","unstructured":"Lally J Byrne F Walsh E . A case of paliperidone-palmitate-induced tardive dyskinesia. Gen Hosp Psychiatry 2013;35:14.","DOI":"10.1016\/j.genhosppsych.2012.04.009"},{"key":"2015081904281628000_114.1.169.39","doi-asserted-by":"crossref","unstructured":"Citrome L . Asenapine review, part II: clinical efficacy, safety and tolerability. Expert Opin Drug Saf 2014;13:803\u201330.","DOI":"10.1517\/14740338.2014.908183"},{"key":"2015081904281628000_114.1.169.40","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0105-7"}],"container-title":["British Medical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bmb\/article-pdf\/114\/1\/169\/5138663\/ldv017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T03:52:17Z","timestamp":1691898737000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bmb\/article-lookup\/doi\/10.1093\/bmb\/ldv017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,6,1]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1093\/bmb\/ldv017"],"URL":"https:\/\/doi.org\/10.1093\/bmb\/ldv017","relation":{},"ISSN":["0007-1420","1471-8391"],"issn-type":[{"value":"0007-1420","type":"print"},{"value":"1471-8391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,8]]}}}